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ABSTRACT Binding of caldesmon to actin causes a decrease in the quantity of bound myosin and results in a reduction in the rate of
actin-activated adenosine triphosphate hydrolysis. It is generally assumed that the binding of caldesmon and myosin to actin is a pure
competitive interaction. However, recent binding studies of enzyme digested caldesmon subfragments directed at mapping the actin
binding site of caldesmon have shown that a small 8-kD fragment around the COOH-terminal can compete directly with the myosin
subfragment 1 (S-1) binding to actin; at least one other fragment that binds to actin does not inhibit the actin-activated adenosine
triphosphate activity of myosin. That is, only a part of the caldesmon sequence may be responsible for directly blocking the binding of
S-1 to actin. This prompts us to question the actual mode of binding of intact caldesmon and myosin S-1 to actin: whether the entire intact
caldesmon molecule is competing with S-1 binding (pure competitive model) or just a small part of it (mosaic multiple-binding model). To
answer this question, we measured the amount of myosin S-1 and caldesmon bound per actin monomer as a function of the total
concentration of S-1 added to the system at constant concentrations of actin and caldesmon. A formalism for calculating the titration
data based on the pure competitive model and a mosaic multiple-binding model was then developed. When compared with theoretical
calculations, it is found that the binding of caldesmon and S-1 to actin cannot be pure competitive if no cooperativity exists between S-1
and caldesmon. In contrast, the mosaic multiple-binding model can fit the binding data rather well regardless of the existence of
cooperativity between S-1 and caldesmon.
INTRODUCTION
Caldesmon is a protein present in both smooth muscle
(1) and nonmuscle (2, 3) cells, which inhibits superpre-
cipitation (4) and the actin activation of adenosine tri-
phosphate (ATP) hydrolysis by myosin (5-10). The
NH2-terminal region ofcaldesmon binds to myosin (1 1-
14) and possibly to calmodulin (15). The interaction of
caldesmon with myosin occurs primarily through the
subfragment 2 region of myosin (11, 13, 14), although
there is a small degree ofinteraction with subfragment 1
(S- 1) (1 1, 13). The affinity ofcaldesmon for myosin sub-
fragments decreases in the following order: smooth
heavy meromyosin (HMM) > skeletal HMM > smooth
S-1 > skeletal S- 1. The COOH-terminal region ofcaldes-
mon binds to actin (16-19), calmodulin (15, 16, 17, 19-
21), and tropomyosin (8, 22-24). The binding of caldes-
mon to actin is associated with inhibition of adenosine
triphosphatase (ATPase) activity. The center region of
caldesmon, which is absent in nonmuscle caldesmons
(25), has a highly helical structure (24, 26, 27) and has no
known activity.
The inhibition of actin-activated ATP hydrolysis by
caldesmon was shown to occur with a decrease in the
degree of binding of S- I to actin (10, 11, 28, 29), and it
was proposed that caldesmon is a competitive inhibitor
ofthe binding ofmyosin to actin (10). Caldesmon was a
less-effective inhibitor of the binding of S-1 to actin in
the presence of pyrophosphate (PPi) (10), 5'-adenylyl
imidodiphosphate (AMPPNP) (11), and in rigor (11).
However, under these conditions, in which the binding
of S-1 to actin is favored, S-1 readily displaces bound
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caldesmon from actin (1 1). Caldesmon and a 20-kD ac-
tin binding fragment ofcaldesmon also inhibit the bind-
ing of myosin-ATP to actin in skinned muscle fibers
(30). In support of this competitive binding model, the
ATPase activity of chemically cross-linked acto-S- 1 was
not inhibited by caldesmon (31). Furthermore, caldes-
mon binds to the NH2-terminal region of actin (31-33)
that has been implicated in the binding of myosin-ATP
to actin (34, 35). Also, the steady-state kinetics of ATP
hydrolysis, in the presence of caldesmon, is character-
ized by an increase in the apparent Km, consistent with a
weakening of the binding of S-1-ATP to actin (36). This
latter point, though, is disputed (37).
Several recent studies directed at mapping the actin
binding site of caldesmon have yielded several polypep-
tides that possess actin binding activity. The whole cal-
desmon molecule binds to -7-10 actin monomers at
full saturation (38). The 35-kD C-terminal fragment of
caldesmon binds to three to four actin monomers (19),
and a 20-kD COOH-terminal fragment, derived from
the 35-kD fragment, binds to only two actin monomers
(39). Finally, an 8-kD fragment from the 20-kD polypep-
tide binds with a 1:1 stoichiometry to actin (40). Intact
caldesmon and the 20-kD fragment both bind to the N-
terminal region of actin (32). The 20- and 8-kD frag-
ments, as well as intact caldesmon, compete with the
binding of S-1 to actin (40). Another region of caldes-
mon, derived from the N-terminal region of 35-kD cal-
desmon fragment, binds to actin but does not inhibit
ATP hydrolysis (41, 42). These results indicate that only
a small part ofthe caldesmon sequence is responsible for
the inhibition of S-I binding to actin. An interesting
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FIGURE 1 Models for simultaneous binding oftwo ligands to a one-di-
mensional lattice. Ligand 1 can cover one lattice subunit, whereas li-
gand 2 can cover three. Ligand 2 has a "head" part which is different
from the rest of the molecule. (a) The pure competitive model. In this
model, ligand binding sites are located at the top side ofthe lattice only.
Thus, subunits covered by one ligand are not available for the other
ligand. (b) A mosaic multiple-binding model. Each lattice subunit has
two ligand binding sites: one located at the top for ligand 2 and the
other at the bottom for ligand 1. Thus, both ligands can bind simulta-
neously to the same subunit of the lattice. Ligand 2 has a "head" part
(indicated by the vertical line) which competes with ligand 1 for the
same binding site at the bottom. Thus, when bound by the head part of
ligand 2, a subunit loses its ability to bind ligand 1.
question is how a relatively small area of the caldesmon
molecule (<20 kD) that binds to actin and inhibits two
molecules of S-I binding to actin can enable the larger
caldesmon molecule to inhibit the binding of additional
S-I molecules.
One possible solution is that part ofa caldesmon binds
relatively strongly to one (or two) actin monomers and
totally inhibits the binding of S-I-ATP to these actin
sites, whereas the other part may bind less tightly to addi-
tional actin sites and partially inhibit the binding ofaddi-
tional S-1 molecules (a mosaic multiple-binding model;
see Fig. 1). In other words, the binding of intact caldes-
mon and S-i to actin may not be pure competitive. This
possibility is now explored by analyzing a ligand titration
experiment in which the amount of bound S- I and cal-
desmon molecules per actin monomer is measured as a
function of the total concentration of S-1 added to the
system at constant concentrations of actin and caldes-
mon. When the data were compared with model calcula-
tions, it was found that the binding ofS- I and caldesmon
to actin cannot be purely competitive unless coopera-
tivity between S-I and caldesmon is assumed. On the
other hand, the moaic multiple-binding model can fit
the experimental data easily, regardless of the assump-
tion of cooperativity.
Since the mosaic multiple-binding model used in this
paper is new, we first describe the model and the proce-
dure for the fitting of the model to the titration experi-
ment.
MODEL AND MATHEMATICAL ANALYSIS
Competitive and multiple-binding
models
We will consider a binding system involving two kinds of
ligands: a short ligand 1 (S-I in this study) that can bind
to only one lattice subunit and a long ligand 2 (caldes-
mon) that can cover n (n = 7 for caldesmon; see refer-
ence 38) lattice subunits when bound to the lattice.
As shown in Fig. 1 a, if each lattice subunit has only
one ligand binding site and both ligand 1 and ligand 2
can only bind to the same site, then the binding is purely
competitive (pure competitive model). In this case, a sub-
unit, when covered by one ligand, is not able to bind with
another ligand. In contrast, if a subunit has two kinds of
ligand binding sites, one for ligand 1 and the other for
ligand 2, then a lattice subunit may be covered simulta-
neously by both ligands. That is, ligand 1 can still bind to
the lattice subunits that are already bound with ligand 2
(and vice versa), although the binding strength may be
altered. This mode of binding is called a multiple-bind-
ing model. If the effect of ligand 2 on the binding
strength ofligand 1 is uniform for all subunits covered by
the same ligand 2, the model is referred to as a "uni-
form" multiple-binding model. Since ligand 2 is a long
ligand, it is possible that different parts of ligand 2 may
exert different effects on the binding of ligand 1 to the
lattice subunits that are covered by the same ligand 2.
That is, the binding of ligand 1 to a subunit already
bound with ligand 2 may not be uniform along the
length of ligand 2. In this case, the binding model is
called a "mosaic" multiple-binding model.
In this paper, we consider a special mosaic multiple-
binding model for the simultaneous binding of S- I and
caldesmon to actin in which the effect of bound caldes-
mon on S- I binding is uniform for all actin monomers
along the length of a bound caldesmon, except one
monomer that does not bind S-I at all (the binding ofS-I
to this monomer is prohibited). That is, among the seven
actin monomers covered by a caldesmon molecule, one
monomer completely loses its ability to bind S- 1,
whereas the rest bind S-I with a common binding con-
stant. This model is based on the finding mentioned
above that only a small part of caldesmon is actually
competing with S-I for the same binding site on actin.
Since the detailed structure ofa bound caldesmon mole-
cule on actin is not known, it is hard to determine where
the S-I competing part of a caldesmon molecule is lo-
cated. However, if interaction (cooperativity) between
two neighboring S-I molecules on actin does not exist,
then the binding formalism to be developed below will
not depend on the exact position on a caldesmon mole-
cule of this S-I competing part. It is known that S-I
binds noncooperatively to bare actin (see below). It is
reasonable to assume that S- I binds similarly to caldes-
mon-bound actin. Thus, we arbitrarily assume in this
model that the S- I competing part ofa caldesmon mole-
cule is located at its "head" (see Fig. 1 b).
It is known that actin has polarity. It is reasonable to
assume that the two ends of a caldesmon molecule are
also structurally different. Thus, it is possible that the
binding of caldesmon to actin may depend on the rela-
tive orientation of their polarities. For simplicity, we as-
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etal S-I-AMP PNP to actin and actin-tropomyosin was
measured under identical conditions and is shown in
Fig. 2. S-I binds to actin without any apparent coopera-
tivity and is facilitated by smooth muscle tropomyosin.
The binding isotherm for S-I-AMP PNP is reasonable in
regard to data obtained at different experimental condi-
tions (43, 44). The parameters characterizing the binding
of caldesmon or S- I to actin are given in Table 1.
The binding parameters in Table 1 are used for both
models without change. Thus, the only unknown param-
eters in the pure competitive model are the two coopera-
tivity parameters between S- I and the two ends of a cal-
desmon molecule. On the other hand, additional bind-
ing constants are needed in the mosaic multiple-binding
model: K'1, the binding constant of S-i to an isolated
actin monomer already bound with a caldesmon, and
K2S, s = 1, 2, ... ., the binding constants ofcaldesmon to
an aggregate of seven actin monomers already bound
with s S-1 molecules (see Fig. 3). Since the binding ofS- I
to caldesmon-covered actin is assumed to be noncooper-
ative (see before), the value of K2S can be shown easily
(e.g., see Fig. 3) to be related to K'1 as
K2, = K20(K'IKl
S = 1, 2, ... , n - 1, (1)
[S-i ]free
FIGURE 2 Binding of S- I to actin in the presence (0) and absence (0)
of smooth muscle tropomyosin. Binding was measured using either
['4C1-labeled S- I (a) or using unmodified S- I (0) as described in Mate-
rials and Methods. Binding was measured at 25°C in solutions contain-
ing 4 mM AMPPNP, 4.8 mM MgCl2, 42 mM NaCl, 9.6 mM imidaz-
ole-HCl, pH 7.0,0.25 mM EGTA, 0.6 mM dithiothreitol, 10AM actin,
2.8 AM smooth muscle tropomyosin, where applicable, and variable
concentrations of skeletal S-1. The data were fit by theoretical curves
giving association constants of6.25 and 1.95 x I05 M` in the presence
and absence of tropomyosin, respectively.
sume that caldesmon binds with only one direction (see
Fig. 1 b). In this case, there is only one binding constant
and one cooperativity parameter for the binding of cal-
desmon to actin. One must note that this assumption is
made only to simplify the mathematical analyses to be
presented below and that this assumption has been used
implicitly in the analyses ofbinding ofcaldesmon to ac-
tin (38).
Binding constants and cooperativity
parameters of the models
An analysis of the competition between caldesmon and
S-1 requires that the binding of each ligand to actin be
characterized first in the absence ofthe other ligand. Cal-
desmon has been shown to bind to about seven actin
monomers with a slight degree of cooperativity (38).
This interaction is strengthened somewhat by the pres-
ence ofsmooth muscle tropomyosin. The binding ofskel-
where K1 and K20 are the binding constants of S-I and
caldesmon, respectively, to bare actin (Table 1). Thus,
all binding constants ofthe system can be obtained when
the value of K'1 is known. In principle, K'1 can be ob-
tained experimentally by measuring the binding iso-
therm ofS- I to caldesmon-saturated actin. In this paper,
we will treat it as an adjustable parameter. It is important
to note that when K'1 = 0, the mosaic multiple-binding
model becomes equivalent to a pure competitive bind-
ing model.
O,-O,, curve
The titration experiment carried out in this study in-
volves the measurement of fractions of bound S-1 and
caldesmon per actin monomer (0I and OII) at various con-
centrations of the total S-1 present in the system (C°),
with the total concentrations of actin (C°) and caldes-
mon (Ca) in the system being kept constant. The mea-
TABLE 1 Basic binding parameters of S-1 and caldesmon
With Without
tropomyosin tropomyosin
Binding S-1, K1 0.625 x 106 M-' 0.2 x 106 M-'
constant Caldesmon, 1.9 x 106 0.55 x 106
K20
Cooperativity S- 1, y' 1 I
Caldesmon, 4 3
y
Chen and Chalovich Mosaic Multiple-binding Model
1.0
e
Chalovich Mosaic Multiple-binding Model 1 065
Ooo) + 0
y00+-
K1
4-
K,4-
QOO)
binding models. Recently, Chen (45) has developed a
very simple procedure in deriving the secular equation
(and therefore the binding isotherms) of the system that
is applicable to many binding models, including the mo-
saic model discussed in this paper. In the Appendix, the
application of the procedure to the present model is
briefly discussed. The final expressions for the binding
isotherms are obtained as
oI (D) (75 -xII(l +XIb) *[o(n - l)(y- 1 - y)
+ (1 + nXI)(Y- YiaYib + (1 Yla)( Ylb) JJ (4)
( D ) (
000 K20 (1 -Yla)(1 -Ylb)TlL ii~~~~~~~Y
where
D = n+l - nyn(l + XI - )
n- + I°l * (1 - Yla)(1 - Ylb)
- x11(l + x15) [. Yi. + Yi (6)
K l
O = K1C1
XI = K2CII1
FIGURE 3 The two possible reaction routes for the formation of unit
six in Fig. 1 b. The K's are the equilibrium binding constants of the
reactions. From these reactions, the weighting factor ofunit six, x6, can
be written down easily.
sured 01 at a number ofC° values are then plotted against
the corresponding 0I, as those shown in Fig. 4. In this
section, we show how to calculate the 0}I-01 curves for the
pure competitive and the mosaic binding models.
Let CI and CII be the concentrations of free S-1 and
free caldesmon in solution when the total concentrations
of actin, S-1, and caldesmon in the system are CO, C°,
and CO, respectively. Then, the conservation ofmaterial
requires that
Co = Co 0A+ CI
Co = co * oII + CII.
(2)
(3)
At constant C° and COI, the values of 0I and 9II at any C°
can be evaluated from Eqs. 2 and 3 ifwe have the bind-
ing isotherms of the system, which describe the relation
between the amount of ligands that are bound to actin
(0k, 0,I) and the concentrations of free ligands in solution
(CI, CII).
Many statistical mechanical techniques can be used to
derive the binding isotherms of one-dimensional ligand
(7)
(8)
(9)
y is the cooperativity parameter between two caldesmon
molecules, Yia and Ylb are those between S-1 and the two
ends of a caldesmon molecule, and 'y is the largest root
of the secular equation:
fy (1 + XI °) X(, + xIO). {y'(Y 1) Y2y
+ XI* [Y(Y - YlaYlb) + (1 - Yla)( - Ylb)} = 0. (10)
Two points are emphasized here. First, the binding
isotherms in Eqs. 4 and 5 are applicable to both the pure
competitive and the mosaic multiple-binding models
discussed in this paper. The pure competitive case is ob-
tained by setting the value of 6 to zero. Second, the only
unknown or adjustable binding parameters in Eqs. 4-10
are 6 (or K'), Yia, and Ylb. The others are known and
listed in Table 1.
The values of 01 and 0,I at different CO (at constant CO
and CO) can be evaluated numerically from Eqs. 2 to 5
with the use of Eqs. 6-10. For simplicity, Yia is set equal
to Ylb in all calculations. That is, no difference in interac-
tion is assumed between the head and the end ofa caldes-
mon and a S-1 molecule.
MATERIALS AND METHODS
Rabbit back and leg muscle was the source of actin (46, 47), myosin
(48), and myosin S- I (49). Tropomyosin (50) and caldesmon (38) were
isolated from turkey gizzards. The concentrations ofactin and S-1 were
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determined by absorbance measurements at 280 nm, whereas the
Lowry assay (with a bovine serum albumin standard) was used for
other proteins. We have shown earlier that the Lowry assay gives the
true protein concentration for caldesmon (38); this is essential for bind-
ing studies. The molecular weights were assumed to be 120,000 for S- 1,
42,000 for actin, 68,000 for tropomyosin, and 86,974 for caldesmon
(26). (The estimate of the molecular weight of caldesmon has contin-
ued to change from 140,000 (1) to 97,000 (51) and recently to 86,974
(26). Previous estimates ofbinding constant and cooperativity parame-
ter for the binding of caldesmon to actin were based on the molecular
weight of97,000 (38). The corrected values based on the new molecular
weight are listed in Table 1.)
The binding of S- I or caldesmon to actin was measured by a cosedi-
mentation assay. Myosin S-1 was used in the competition experiments
since there is little, if any, interaction between caldesmon and skeletal
S- 1. Myosin S- I and/or caldesmon were mixed with skeletal F-actin at
0°C in a solution containing 4 mM AMP-PNP, 4.8 mM MgCl2, 42
mM NaCl, 9.6 mM imidazole-HCl, pH 7.0, 0.25 mM ethyleneglycol-
bis(,B-aminoethyl ether)-N,N'-tetraacetic acid, and 0.6 mM dithio-
threitol. After incubation at 25°C for 20 min, the mixture was centri-
fuged at 160,000 g for 25 min at 25°C to sediment the actin and bound
ligand. The supernatant was carefully removed, and the free ligand
protein concentration was determined. The concentration of bound
ligand was determined from the free and total ligand concentrations. In
the case of skeletal S- l, the free ligand concentration was determined
either by measuring the NH4+-ethylenediaminetetraacetate ATPase
rate ofthe S-l in the supernatant (52) or by preparing ['4C]-labeled S-1
and determining the loss of radioactivity in the supernatant after cen-
trifugation. The labeled S-1 was prepared by reaction with ['4C]-
iodoacetamide and was purified before use by ATP-agarose affinity
chromatography ( 10). Free caldesmon was determined by using a radio-
active probe. Caldesmon was modified with either ['4C]iodoacetamide
or 125I and purified using cellulose phosphate chromatography (38).
Binding values were corrected for the amount of S-1 and caldesmon
that sedimented even in the absence ofactin (5-10%), as well as for that
fraction ofligand that did not bind even in the presence ofa large excess
of actin (negligible for S-1 but 10% for ['4C]caldesmon and 25% for
['25I]caldesmon).
RESULTS AND DISCUSSION
The purpose ofthis paperwas to study whether the simul-
taneous binding ofcaldesmon and myosin S- 1 molecules
to actin can be described by a mosaic multiple-binding
model, instead of the usual competitive model. In this
model, some of the actin monomers when bound with
caldesmon can still bind S- 1. The motivation comes
from the recent findings that not all ofthe small subfrag-
ments of an enzyme-digested caldesmon are directly
competing with S- 1 in binding to actin (16, 18-20, 28).
To this end, we first carried out a ligand titration experi-
ment in which S- 1 was added to a system containing
fixed amount of actin and caldesmon, and values of 01
and 01, (bound S- 1 and caldesmon per actin monomer)
were measured at different S- 1 concentrations. The data
were then compared with those calculated theoretically
from the model. To test the effect oftropomyosin on the
binding, two types ofactins were used in the study: actins
with and without tropomyosin. In each case, the titra-
tion experiment was carried out at two caldesmon con-
centrations. The experimental and calculated results are
shown in Fig. 4.
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FIGURE 4 The 0I-@0I curves in the absence (a and b on the left) and
presence (cand d) oftropomyosin. Each panel represents a S-l titration
experiment with constant actin and caldesmon concentrations. In all
four cases, the concentration of actin is fixed at 7.14 ,M. The concen-
tration of caldesmon (in units of ,uM) is shown in each figure. The
measured data are shown as filled circles. The solid curves are those
calculated for the mosaic multiple-binding model described in the text
with Yia = Ylb = 1 (no cooperativity between S-l and caldesmon). The a
value for the two panels on the right (actin with tropomyosin) is 0.3 and
0.6 for those on the left. The two broken curves in each figure are those
calculated from the pure competitive model. The case without cooper-
ativity between S-l and caldesmon (Yla = Ylb = 1) is represented by the
dashed curve. The dashed curve with dots is for the case that Yla = Ylb =
5.
Because of the difficulty of simultaneously measuring
the binding oftwo ligands, the measured data are rather
scattered. However, because ofthe large difference in the
calculated curves for different binding models, the fol-
lowing interesting points can be readily observed from
Fig. 4. (a) For the pure competitive model, ifno coopera-
tivity exists between bound S- 1 and caldesmon, then the
fitting of the model with experiment is rather poor (see
the dashed curves in the figure). (b) However, the fitting
ofthe model improves slightly when a small cooperativ-
ity (Yia = Ylb = 5) is invoked between S-l and caldesmon
(the broken curves with dots). (c) On the other hand, the
mosaic multiple-binding model discussed in this paper
can fit the experimental data reasonably well, even with-
out cooperativity between S- 1 and caldesmon (the solid
curves). (d) If the binding is of the mosaic model, then
the effect of bound caldesmon on actin monomer is to
reduce the S-1 binding affinity (6 is always <1 or Kl is
always <K,), and the effect is stronger when the actin is
saturated with tropomyosin (6= 0.3) than without tropo-
myosin (6 = 0.6). From these findings, it is reasonable to
conclude that the mosaic multiple-binding model dis-
cussed in this paper works well in describing the simulta-
neous binding of caldesmon and S-1 to actin. In con-
trast, the binding cannot be ofthe pure competitive type
if there is no cooperativity between S- 1 and caldesmon.
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However, the pure competitive model is not completely
ruled out if cooperativity exists between S-1 and cal-
desmon.
One must note that in this paper we have discussed
only the mosaic model that just one of the seven actin
monomers covered by the same caldesmon is assumed
to be excluded from S-1 binding. In fact, it has been
found that this mosaic model can still fit the experimen-
tal data even iftwo or three ofthe seven actin monomers
lose the S- 1 binding ability (data not shown). In these
cases, the value of 6, the ratio ofthe binding constants of
S- 1 to bare and to caldesmon-covered actin monomers,
becomes larger.
The mosaic multiple-binding model discussed in this
paper implies that only a small part ofa caldesmon mole-
cule is directly competing with S- 1 for the same binding
site on actin. This agrees rather well with recent struc-
tural studies in which the actin binding sites on a caldes-
mon are mapped by measuring the binding of various
enzyme digested subfragments of a caldesmon (19, 39).
The finding that reduction in the binding of S-1 to cal-
desmon-covered actin monomers is larger when the ac-
tin is saturated with tropomyosin is in line with the
greater inhibition of actin-activated S- 1 ATPase activity
by caldesmon in the presence of tropomyosin (29, 38,
53). This is consistent with the suggestion that the inhibi-
tion of S-1 ATPase activity by caldesmon is primarily
due to a reduction in Kapp (30, 36).
We would like to emphasize that the binding titration
experiment presented in this paper was carried out by
changing the total concentration ofS- 1 (C°) at a constant
caldesmon concentration. A similar experiment would
be to titrate the binding system with caldesmon instead
of S- 1. The same formalism presented in this paper can
be applied directly to this case.
Finally, we would like to point out that the present
formalism is also useful for analyzing the binding of cal-
desmon fragments and S-1 to actin. In fact, the simulta-
neous binding of S- 1 and the 20-kD fragment to actin
has been studied recently (L. Velaz and J. M. Chalovich,
personal communication). The preliminary results show
that each fragment covers two actin monomers and that
the binding is pure competitive. A possible implication
of this finding is that the number of actin monomers
excluded from S- 1 binding by a bound caldesmon mole-
cule may be two instead of one.
In conclusion, we propose in this paper a mosaic multi-
ple-binding model for the simultaneous binding of S-1
and caldesmon to actin. We also present a formalism for
analyzing the binding of a two-ligand titration experi-
ment based on the model. The formalism is new and is
useful in analyzing other two-ligand multiple-binding
systems, such as in tropomyosin-myosin-actin binding
system. In this system, tropomyosin molecules bind to
the helix groove of actin (actin is a double-stranded he-
lix) and myosin molecules bind to the sites on the outer
surface of each actin monomer, forming a double-bind-
ing structure (54, 55). In general, the possibility ofhaving
a multiple-binding mechanism exists when the lattice for
ligand binding is a double- or multiple-stranded polymer
(such as actin, DNA, or microtubule).
APPENDIX
Derivation of binding isotherms of a
mosaic multiple-binding model
In this appendix, the binding isotherms of S- -caldesmon-actin bind-
ing system will be derived for the mosaic multiple-binding model de-
scribed in the text, using the procedure developed recently by Chen
(45). For simplicity, we will start with the n = 3 case (a caldesmon
molecule is assumed to cover only three actin monomers when bound;
see Fig. 1 b) and extend the results to an arbitrary n at the end. As
mentioned before, the mosaic model reduces to a pure competitive
model when K; (or 6) is set to zero. Thus, the binding isotherms derived
here are also applicable to the pure competitive case.
As shown in Fig. 1 b, there are six elementary units in this binding
system. Let the cooperativity parameters between S- I and the two ends
of a caldesmon molecule be denoted as Yia and Ylb and between two
caldesmon molecules as y. Then, as shown by Chen (45), the secular
equation of this binding system can be obtained as
I -e'
X2
x3
x4
x5
X6
X2 -
X3Y1b
X4YJb
X5Y1b
XJlIb
X2y1a
X3Y-Y
x4y
x5y
X6Y
X2Y1a
x3Y
X4y-
x5y
x6y
X2YIa
x3y
x4y
X5Y
X63,
X2Y1a
x3y
X42V
x5y
X6Y-
= 0, (Al)
where xi, i = 1, 2,..., 6, is the "weighting factor" of the elementary
unit i. The value ofxi can be expressed as the product ofbinding poten-
tials of all binding reactions leading to the formation of unit i (45). For
example, as shown in Fig. 3, x6 can be expressed as
X6 = K22C,I (K1C1)2, (A2)
or
X6 = K20C11 (KC1)2. (A3)
From these two equations, the relation in Eq. can be easily verified.
Using Eqs. 7-9, the weighting factors ofthe six elementary units in Fig.
1 b can be easily identified as
XI =
X2 = XI
X3 = XII
X4 = 6XIXII
X5 = bXIXII
x6 = (bXI)2XII. (A4)
After carrying out the following two sets of operations-(a) succes-
sively substracting column from column 2, column 4 from column 3,
column 5 from column 4, et cetera, followed by (b) adding row 2 to row
1, row 3 to row 4, row 4 to row 5, et cetera-the matrix in Eq. Al can be
transformed into a partial diagonal form and reduced to
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I1+ X2-z 0 + X2Yla
X2 -ly X2Y1a = 0, (A5)
where
X3 + X4 + X5 + X6 = XII(I + XI6)2 * (A6)
It is easy to show that the secular equation in Eq. A5 is applicable to
any n value, if the 2: in Eq. A6 is replaced by
2 = XII(l + Xjb)*. (A7)
After expanding the determinant in Eq. A5, the polynomial form ofthe
secular equation in Eq. 10 for an arbitrary n is obtained.
The analytical expressions of 01 and OH can be obtained from this
secular equation using the relations:
0' = lnxl ' (A8)
cl In y,
anx=X' (A9)
where a, is the largest root of the secular equation of the system (Eqs.
A5 or 10). Thus, after differentiating Eq. 10 with respect to xl and x11,
respectively, and substituting the y in the resulting equations with 'y,
the binding isotherms in Eqs. 4 and 5 are obtained.
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